First-Line Treatment for Hypertension
The first-line treatment for hypertension includes lifestyle modifications and pharmacological therapy with one of four medication classes: thiazide or thiazide-like diuretics, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), or calcium channel blockers (CCBs). 1, 2, 3
Lifestyle Modifications
Lifestyle modifications should be implemented for all patients with blood pressure >120/80 mmHg:
- Weight loss or maintenance of healthy body weight for overweight or obese individuals 2, 4
- DASH (Dietary Approaches to Stop Hypertension) eating pattern with reduced sodium (<2,300 mg/day) and increased potassium intake 2, 4
- Regular physical activity (at least 150 minutes of moderate-intensity aerobic activity per week) 2, 4
- Moderation of alcohol consumption (≤2 drinks/day for men, ≤1 drink/day for women) 2, 4
- Smoking cessation 2, 4
Pharmacological Therapy
First-Line Medication Classes
Four medication classes are recommended as first-line therapy:
- Thiazide or thiazide-like diuretics (preferably long-acting agents like chlorthalidone or indapamide) 1, 2
- ACE inhibitors (e.g., lisinopril) 1, 2, 5
- ARBs 1, 2
- Dihydropyridine calcium channel blockers (e.g., amlodipine) 1, 2, 6
Initial Treatment Strategy Based on BP Severity
- For patients with BP between 130/80 mmHg and 150/90 mmHg: Start with a single drug 2
- For patients with BP ≥150/90 mmHg: Initial treatment with two antihypertensive medications 2
Special Population Considerations
Black Patients
- Calcium channel blockers or thiazide diuretics are recommended as first-line monotherapy 1, 2
- When combination therapy is needed, use a CCB plus a thiazide-like diuretic or CCB plus an ARB 1
Patients with Albuminuria or Coronary Artery Disease
- ACE inhibitor or ARB is recommended as first-line therapy 2
Treatment Algorithm
Stage 1 Hypertension (BP 130-159/80-99 mmHg):
For Non-Black Patients:
For Black Patients:
Important Considerations
- Target BP should generally be <130/80 mmHg for most adults, with individualization for elderly patients based on frailty 1, 2
- Monitor serum creatinine and potassium levels when using ACE inhibitors, ARBs, or mineralocorticoid receptor antagonists 2
- Single-pill combinations may improve medication adherence 2
- Avoid combining ACE inhibitors with ARBs due to increased risk of adverse effects without additional benefit 2
- For patients with resistant hypertension, consider adding spironolactone or other agents (amiloride, doxazosin, eplerenone, clonidine, or beta-blocker) 1